Clinical Trial Update: A Clinical Trial To Evaluate Efficacy And Safety Of Levophencynonate Hydrochloride In Patient With Vertigo [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating levophencynonate hydrochloride for vertigo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vertigo

Drugs mentioned

• Levophencynonate hydrochloride (levophencynonate hydrochloride)

Snippet

Sponsor: Sihuan Pharmaceutical Holdings Group Ltd. | Conditions: Vertigo | Phase 2 | Status: COMPLETED